GLP-1 receptor agonists can help treat obesity and promote weight loss by slowing gastric emptying, making you feel fuller longer, and also slowing the release of glucose into your bloodstream
Better yet, wait 6-8 weeks if you are experiencing fatigue or significant GI symptoms at your current dose
Semaglutide is a GLP-1 (glucagon-like peptide-1) weight loss medication that comes as three brand-name drugs, Wegovy, Ozempic, and Rybelsus, each approved by the U.S
Hence, while oral semaglutide and SGLT2 inhibitors offer comparable benefits for glycemic control and weight reduction, clinicians must consider the potential for skeletal muscle loss when prescribing SGLT2 inhibitors, particularly in those vulnerable to sarcopenia or frailty
Social Proof "I couldn't afford Wegovy without insurance
These medications have complex dosing schedules, and starting too fast or without guidance can lead to side effects like nausea, light headedness, and adverse effects like serious gastrointestinal problems
